- Home
- VSEC vs HRMY Comparison
VSEC vs HRMY Comparison
Compare VSEC & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSEC
- HRMY
- Stock Information
- Founded
- VSEC 1959
- HRMY 2017
- Country
- VSEC United States
- HRMY United States
- Employees
- VSEC N/A
- HRMY N/A
- Industry
- VSEC Military/Government/Technical
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- VSEC Consumer Discretionary
- HRMY Health Care
- Exchange
- VSEC Nasdaq
- HRMY Nasdaq
- Market Cap
- VSEC 2.1B
- HRMY 2.0B
- IPO Year
- VSEC N/A
- HRMY 2020
- Fundamental
- Price
- VSEC $116.63
- HRMY $33.19
- Analyst Decision
- VSEC Strong Buy
- HRMY Strong Buy
- Analyst Count
- VSEC 6
- HRMY 8
- Target Price
- VSEC $118.67
- HRMY $54.00
- AVG Volume (30 Days)
- VSEC 252.4K
- HRMY 670.3K
- Earning Date
- VSEC 05-07-2025
- HRMY 04-29-2025
- Dividend Yield
- VSEC 0.35%
- HRMY N/A
- EPS Growth
- VSEC N/A
- HRMY 17.84
- EPS
- VSEC 0.85
- HRMY 2.51
- Revenue
- VSEC $1,080,132,000.00
- HRMY $714,734,000.00
- Revenue This Year
- VSEC $11.84
- HRMY $20.92
- Revenue Next Year
- VSEC $10.43
- HRMY $18.83
- P/E Ratio
- VSEC $136.00
- HRMY $13.22
- Revenue Growth
- VSEC 25.53
- HRMY 22.80
- 52 Week Low
- VSEC $73.36
- HRMY $28.14
- 52 Week High
- VSEC $128.72
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- VSEC 51.48
- HRMY 43.39
- Support Level
- VSEC $117.40
- HRMY $32.85
- Resistance Level
- VSEC $128.72
- HRMY $33.77
- Average True Range (ATR)
- VSEC 5.12
- HRMY 1.21
- MACD
- VSEC -0.22
- HRMY 0.03
- Stochastic Oscillator
- VSEC 28.80
- HRMY 28.66
About VSEC VSE Corporation
VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management and consulting services for land, sea and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. Majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business and general aviation operators.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.